BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19495684)

  • 1. Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumors.
    Medarova Z; Kumar M; Ng SW; Moore A
    Methods Mol Biol; 2009; 555():1-13. PubMed ID: 19495684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Magnetic Resonance Imaging of Small Interfering RNA Nanodelivery to Pancreatic Islets.
    Wang P; Moore A
    Methods Mol Biol; 2016; 1372():25-36. PubMed ID: 26530912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided breast tumor therapy using a small interfering RNA nanodrug.
    Kumar M; Yigit M; Dai G; Moore A; Medarova Z
    Cancer Res; 2010 Oct; 70(19):7553-61. PubMed ID: 20702603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of siRNA delivery and silencing in tumors.
    Medarova Z; Pham W; Farrar C; Petkova V; Moore A
    Nat Med; 2007 Mar; 13(3):372-7. PubMed ID: 17322898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
    Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
    Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic poly(lactic-co-glycolic acid) nanoparticle for magnetic resonance/infrared fluorescence bimodal imaging and efficient siRNA delivery to macrophages and its evaluation in a kidney injury model.
    Yang C; Vu-Quang H; Husum DMU; Tingskov SJ; Vinding MS; Nielsen T; Song P; Nielsen NC; Nørregaard R; Kjems J
    Nanomedicine; 2017 Nov; 13(8):2451-2462. PubMed ID: 28842376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
    Gu J; Al-Bayati K; Ho EA
    Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.
    Kim SW; Kim NY; Choi YB; Park SH; Yang JM; Shin S
    J Control Release; 2010 May; 143(3):335-43. PubMed ID: 20079391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.
    Kenny GD; Kamaly N; Kalber TL; Brody LP; Sahuri M; Shamsaei E; Miller AD; Bell JD
    J Control Release; 2011 Jan; 149(2):111-6. PubMed ID: 20888381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional siRNA-Laden Hybrid Nanoplatform for Noninvasive PA/IR Dual-Modal Imaging-Guided Enhanced Photogenetherapy.
    Feng J; Yu W; Xu Z; Hu J; Liu J; Wang F
    ACS Appl Mater Interfaces; 2020 May; 12(20):22613-22623. PubMed ID: 32338491
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.